2015
DOI: 10.1155/2016/9176357
|View full text |Cite
|
Sign up to set email alerts
|

Spheroid Culture of Mesenchymal Stem Cells

Abstract: Compared with traditional 2D adherent cell culture, 3D spheroidal cell aggregates, or spheroids, are regarded as more physiological, and this technique has been exploited in the field of oncology, stem cell biology, and tissue engineering. Mesenchymal stem cells (MSCs) cultured in spheroids have enhanced anti-inflammatory, angiogenic, and tissue reparative/regenerative effects with improved cell survival after transplantation. Cytoskeletal reorganization and drastic changes in cell morphology in MSC spheroids … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

16
364
0
2

Year Published

2016
2016
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 371 publications
(411 citation statements)
references
References 134 publications
16
364
0
2
Order By: Relevance
“…Currently, there are more than 300 registered clinical trials (www.clinicaltrials.gov) in which MSC are used to treat several different diseases, with applications ranging from bone and cartilage repair to spinal cord, cardiac, and bladder regeneration (Kramer et al 2012). Three-dimensional (3D) MSC aggregates, typically known as ''spheroids'', have been demonstrated to improve several MSC features, such as multilineage potential, secretion of proangiogenic and chemotactic factors, resistance against hypoxic condition (Sart et al 2014), and, moreover, to enhance stemness (Cesarz and Tamama 2016) and anti-inflammatory properties (Ylöstalo et al 2012). Cellular spheroids are essentially micro-tissues built in vitro to resemble the native configuration of cells in vivo (Berenzi et al 2015), with a microenvironment that allows direct cell-cell signalling and cell-matrix interactions, thus better preserving MSC phenotype and innate properties (Bartosh et al 2010).…”
Section: Introductionmentioning
confidence: 99%
“…Currently, there are more than 300 registered clinical trials (www.clinicaltrials.gov) in which MSC are used to treat several different diseases, with applications ranging from bone and cartilage repair to spinal cord, cardiac, and bladder regeneration (Kramer et al 2012). Three-dimensional (3D) MSC aggregates, typically known as ''spheroids'', have been demonstrated to improve several MSC features, such as multilineage potential, secretion of proangiogenic and chemotactic factors, resistance against hypoxic condition (Sart et al 2014), and, moreover, to enhance stemness (Cesarz and Tamama 2016) and anti-inflammatory properties (Ylöstalo et al 2012). Cellular spheroids are essentially micro-tissues built in vitro to resemble the native configuration of cells in vivo (Berenzi et al 2015), with a microenvironment that allows direct cell-cell signalling and cell-matrix interactions, thus better preserving MSC phenotype and innate properties (Bartosh et al 2010).…”
Section: Introductionmentioning
confidence: 99%
“…There has been a growing interest in using 3D nonadherent culture platforms to understand MSC biology better and enhance MSC-based therapies (22)(23)(24). By mirroring natural conditions in vivo, 3D cultures are superior to 2D cultures for understanding complex cell-to-cell and cell-to-matrix interactions, and therefore…”
mentioning
confidence: 99%
“…[24,25] The scaffolds can also combine with a variety of hydrogels or biologic matrices/cues to form 3D hybrid scaffolds with eliciting biologically functional molecules. [26][27][28] In addition, these novel 3D scaffolds with cost-effective fabrication could likely lead to the drastic change in the utilization of electrospun nanofibers.…”
Section: Resultsmentioning
confidence: 99%